Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) on Friday, plunged -4.66% from the previous trading day, before settling in for the closing price of $4.51. Within the past 52 weeks, IRWD’s price has moved between $3.79 and $15.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.56% over the past five years. The company achieved an average annual earnings per share of 104.01%. With a float of $155.59 million, this company’s outstanding shares have now reached $156.35 million.
Let’s look at the performance matrix of the company that is accounted for 267 employees.
Ironwood Pharmaceuticals Inc (IRWD) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Ironwood Pharmaceuticals Inc is 2.60%, while institutional ownership is 107.80%. The most recent insider transaction that took place on Aug 12 ’24, was worth 42,316. In this transaction Chief Legal Officer of this company sold 9,910 shares at a rate of $4.27, taking the stock ownership to the 284,661 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Principal Accounting Officer sold 3,107 for $4.27, making the entire transaction worth $13,267. This insider now owns 158,370 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 104.01% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Ironwood Pharmaceuticals Inc (IRWD) is currently performing well based on its current performance indicators. A quick ratio of 3.92 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.71. Likewise, its price to free cash flow for the trailing twelve months is 4.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 0.39 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) saw its 5-day average volume 2.44 million, a negative change from its year-to-date volume of 3.26 million. As of the previous 9 days, the stock’s Stochastic %D was 60.62%. Additionally, its Average True Range was 0.32.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 10.94%, which indicates a significant decrease from 34.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.95% in the past 14 days, which was lower than the 91.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.37, while its 200-day Moving Average is $8.51. Nevertheless, the first resistance level for the watch stands at $4.49 in the near term. At $4.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.79. If the price goes on to break the first support level at $4.20, it is likely to go to the next support level at $4.09. The third support level lies at $3.90 if the price breaches the second support level.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
Market capitalization of the company is 686.88 million based on 156,529K outstanding shares. Right now, sales total 442,740 K and income totals -1,002 M. The company made 94,400 K in profit during its latest quarter, and -860 K in sales during its previous quarter.
